For a research scientist, the most tedious part of a discovery often comes after the experiment. It’s the hours spent manually counting cells in microscope images, measuring lesion sizes in tissue samples, or tracking behavioral changes in model organisms,all tasks that are repetitive, subjective, and prone to human error. The budget for this work isn’t a line item for software; it’s the cost of a postdoc’s time, a bottleneck that slows publication cycles and stretches grant money thin. Countify, a Berlin-based company founded in 2017, is betting that a no-code computer vision platform can automate this analysis layer, turning a manual, spreadsheet-driven process into a reproducible, automated workflow [countifybio.com, retrieved 2024].
The wedge into the academic lab
The core proposition is pragmatic: give biologists a tool to build, train, and deploy custom AI models for image analysis without writing a single line of code. A researcher can upload images, annotate examples of what they need counted or measured, and let the platform’s visual intelligence agents handle the live detection and reporting as new data comes in [countifybio.com, retrieved 2024]. The claimed outcomes are the kind that get a lab manager’s attention,95% detection accuracy and processing that is 120 times faster than manual work, translating to an estimated 50% cost savings on that manual labor [countifybio.com, retrieved 2024]. For the academic user, the platform bundles in cloud storage and report generation tailored for papers. For industry clients in biotech or pharma, it adds analytics and reporting frameworks designed for regulatory compliance [countifybio.com, retrieved 2024]. The go-to-market is a pay-as-you-go model, a sensible fit for grant-funded projects with variable usage.
A long runway with a solo pilot
Countify presents a classic, capital-efficient European deep tech profile. Founded as a solo venture by Cristian Alzati, who lists roles as founder, CEO, CTO, and lead software architect across different sources, the company has been developing its technology since 2017 without a publicly disclosed funding round [GetLatka, Unknown] [Crunchbase, Unknown] [LinkedIn, retrieved 2026]. A third-party service estimates its valuation at $3.9 million, but this is not a confirmed financing event [GetLatka, Unknown]. This lengthy bootstrap period suggests a focus on product development over aggressive sales growth. Alzati, who studied at Universidad Iberoamericana and Stanford University, has maintained a technical profile, recently giving a presentation on the company’s work in mid-2026 [Crunchbase, Unknown] [awalkinthephysical.com, 2026]. The absence of a formal sales or marketing leadership team in the public record points to a company still operating in founder-led, product-validation mode.
| Role | Name | Background Note |
|---|---|---|
| Founder & CEO | Cristian Alzati | Also listed as CTO and Lead Software Architect; studied at Universidad Iberoamericana and Stanford University [Crunchbase, Unknown] [LinkedIn, retrieved 2026]. |
The realistic path to a procurement cycle
The ambition is clear, but the path from a useful tool for a single lab to a standardized piece of enterprise lab software is steep. Countify’s ideal customer profile is not the individual graduate student, but the lab director or core facility manager who oversees a portfolio of projects and feels the pain of inconsistent data analysis across their team. This buyer cares about reproducibility, audit trails, and time-to-publication. They have a budget, but it’s often fragmented across individual grants. The real enterprise sale would be to a pharmaceutical company’s translational research department or a large academic core facility, where the procurement cycle involves security reviews, integration with existing data lakes, and validation against gold-standard manual counts.
The competitive set here is fragmented, which is both an opportunity and a risk. Countify isn’t competing with a single dominant vendor but with a combination of in-house scripts, expensive legacy software suites from instrument manufacturers, and generic cloud AI platforms from hyperscalers that require significant coding expertise to adapt. Its defensibility hinges on a deep understanding of specific biological assay workflows that generic tools lack. The company must prove that its pre-built templates and no-code interface deliver enough time-to-value to displace the familiar, if inefficient, status quo.
What enterprise buyers will want to see next
The next twelve months are critical for moving from a promising tool to a commercial engine. The metrics that will matter for a seed or Series A round are not just website claims, but verified case studies with named academic or industry labs. Traction will be measured in the number of workflows automated, the annual contract value from those first core facility deals, and, crucially, the renewal rate. Can a lab that used Countify for one grant-funded project standardize on it for the next three? The product’s technical claims of accuracy and speed must be validated in peer-reviewed literature or white papers to build credibility with a skeptical, evidence-driven customer base. For a company that has built for seven years, the build phase is largely complete. The new, harder work of scaling a sales motion and proving enterprise-grade retention is just beginning.
Sources
- [countifybio.com, retrieved 2024] Countify, No-Code Computer Vision for Labs | https://www.countifybio.com/
- [GetLatka, Unknown] countify GmbH company profile | https://www.getlatka.com/companies/countify-gmbh/vs/airframe-business-software
- [Crunchbase, Unknown] Cristian Alzati - CTO and Co-Founder @ countify | https://www.crunchbase.com/person/cristian-alzati
- [LinkedIn, retrieved 2026] Cristian Alzati - Lead Software Architect - Countify SAS | https://fr.linkedin.com/in/cristian-alzati
- [awalkinthephysical.com, 2026] Christian’s Talks and Interviews | https://awalkinthephysical.com/interviews/
- [The Org, retrieved 2026] countify GmbH organizational profile | https://theorg.com/org/countify-gmbh